REL and lymphoma: Of highest interest in this context are studies elucidating consequences of enhanced c-Rel signaling in late-stage B cell differentiation—representing the cell types that are the malignant cell type or are major disease drivers or contributors in human lymphoma and autoimmunity, respectively.